ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ATE Antibe Therapeutics Inc

0.43
0.00 (0.00%)
Last Updated: 12:45:10
Delayed by 15 minutes

Antibe Therapeutics Financial Summary

The current ATE market cap is 22.63M. The company's latest EPS is CAD -0.3701 and P/E is -1.16.

Year End March 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 9.54M9.99M10.95M13.6M6.99M
Operating Income -12.19M-16.24M-24.47M-22.02M-14.96M
Net Income -12.82M-19.34M-26.3M-25.06M-19.48M
Year End March 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 14.82M13.84M81.74M89.16M70.56M
Total Liabilities 7.38M10.06M31.48M32.33M30.4M
Total Equity 7.44M3.78M50.26M56.83M40.17M

Cash Flow

Year End March 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -7.06M-11.94M-105k-16.92M-16.31M
Investing -257k98k-264k-20.22M-11.83M
Financing 9.59M12M66.16M-26k80k
Market Cap 22.63M
Price to Earnings Ratio -1.16
Price to Sales Ratio 3.24
Price to Cash Ratio 3.35
Price to Book Ratio 0.56
Dividend Yield -

Share Statistics

Shares Outstanding 52.62M
Average Volume (1 week) 29.12k
Average Volume (1 Month) 187.24k
52 Week Change -25.86%
52 Week High 1.23
52 Week Low 0.30
Spread (Intraday) 0.02 (4.44%)

Company Info

Company Name Antibe Therapeutics Inc
Address 15 prince arthur avenue
toronto, ontario M5R 1B2
Website https://www.antibethera.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock